Infraestructura oncológica en el Sistema de Salud Mexicano

Brau-Figueroa, Hasan; Palafox-Parrilla, Alejandra; Parrilla-Taylor, P.; Mohar, Alejandro

doi:10.21149/12739

Cited by 4 publications

(3 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The system is primarily composed of employment-based social security systems, and medical services for oncological diagnosis and prognosis are inadequate due to limited infrastructure. Mexico has only 212 radiotherapy units, 358 nuclear medicine units, and 2582 imaging units for the entire population [ 46 ]. Therefore, the Mexican government should allocate more resources to improve medical coverage.…”

Section: Discussionmentioning

confidence: 99%

National Burden and Trends for 29 Groups of Cancer in Mexico from 1990 to 2019: A Secondary Analysis of the Global Burden of Disease Study 2019

Beltran-Ontiveros,

Contreras-Gutierrez,

Lizarraga-Verdugo

et al. 2023

Cancers

View full text Add to dashboard Cite

The global burden of cancer is on the rise, with varying national patterns. To gain a better understanding and control of cancer, it is essential to provide national estimates. Therefore, we present a comparative description of cancer incidence and mortality rates in Mexico from 1990 to 2019, by age and sex for 29 different cancer groups. Based on public data from the Global Burden of Disease Study 2019, we evaluated the national burden of cancer by analyzing counts and crude and age-standardized rates per 100,000 people with 95% uncertainty intervals for 2019 and trends using the annual percentage change from 1990 to 2019. In 2019, cancer resulted in 222,060 incident cases and 105,591 deaths. In 2019, the highest incidence of cancer was observed in non-melanoma skin cancer, prostate cancer, and breast cancer. Additionally, 53% of deaths were attributed to six cancer groups (lung, colorectal, stomach, prostate, breast, and pancreatic). From 1990 to 2019, there was an increasing trend in incidence and mortality rates, which varied by 10–436% among cancer groups. Furthermore, there were cancer-specific sex differences in crude and age-standardized rates. The results show an increase in the national cancer burden with sex-specific patterns of change. These findings can guide national efforts to reduce health loss due to cancer.

show abstract

Section: Discussionmentioning

confidence: 99%

National Burden and Trends for 29 Groups of Cancer in Mexico from 1990 to 2019: A Secondary Analysis of the Global Burden of Disease Study 2019

Beltran-Ontiveros,

Contreras-Gutierrez,

Lizarraga-Verdugo

et al. 2023

Cancers

View full text Add to dashboard Cite

show abstract

“…A recent report in Mexico establishes that most cancer services (81%) were delivered by the public while 19% by the private sector ( 13 ). The numbers of specialized cancer units are 118 establishments in total.…”

Section: Public Health System Of Mexicomentioning

confidence: 99%

The health system and access to treatment in patients with cervical cancer in Mexico

et al. 2022

View full text Add to dashboard Cite

Cervical cancer (CC) is tightly related to a low Human Development Index. Mexico is an upper-middle-income country with 126 million inhabitants, and its public health system aims to provide universal health coverage. Currently, employment-based social insurance covers approximately 60% of the population, and the scope of the remaining 40% is on course via the “IMSS-Bienestar” Institute. However, the annual government spending on health remains at 3% of the Gross Domestic Product, which is well below the 6% recommended by the Organization for Economic Cooperation and Development. CC is the second in incidence and mortality among women. Regarding primary prevention with the Human Papilloma Virus-vaccine, the current coverage for girls aged 9 to 14 years is only around 7%. Among secondary prevention with screening, the program is yet to cover the total number of women at risk; nevertheless, the age-standardized CC mortality rate has decreased from 12 per 100,000 women in 1979 to 5.7 per 100,000 women in 2020 due in part to increased screening coverage. Still, around two-thirds of patients present with locally advanced disease at diagnosis. Data from our country demonstrate that even socially disadvantaged CC patients achieve “standard” survival outcomes if treatment is granted. Nevertheless, there is a shortage in almost every aspect regarding CC treatment, including oncologists, chemotherapy units, medical physicists, radiation technicians, and both teletherapy and brachytherapy facilities. In conclusion, advances in the public health system in Mexico are urgently required to achieve CC control and reduce the mortality from this neoplasia that mainly targets socially disadvantaged women.

show abstract

“…Las autoridades locales deben mejorar su capacidad hospitalaria, de dotación, de laboratorios clínicos, de telemedicina como alternativa para el manejo de casos en casa u hospitalizados (Figueroa, 2020), intensificar sus protocolos de atención al Covid -19, fortalecer el primer nivel de complejidad, mejorar su proceso de remisión a niveles de complejidad donde puedan garantizar soporte ventilatorio a los pacientes y atenderlos de forma integral, que la mediana y alta complejidad realice lo que corresponda, en materia de salud pública, intensificar su trabajo comunitario, pero también de auditoria desde la asistencia técnica, el acompañamiento, la regulación a todos los actores del sector salud. Sin dejar de lado mayores garantías para el recurso humano en salud, entrenamiento, dotación, contrataciones dignas y estables.…”

Section: Saludunclassified